Clindamycin Phosphate Injection — FDA Drug Shortage

Current — Baxter Healthcare

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Mar 21, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Baxter Healthcare
Package NDC
0338-3814-50
Dosage Form
Injection
Presentation
Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)
Initial Posting
Mar 21, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.